Published in J Anal Toxicol on October 01, 1996
An evidence based review of acute and long-term effects of cannabis use on executive cognitive functions. J Addict Med (2011) 2.06
Human cannabinoid pharmacokinetics. Chem Biodivers (2007) 1.91
Extended urinary Delta9-tetrahydrocannabinol excretion in chronic cannabis users precludes use as a biomarker of new drug exposure. Drug Alcohol Depend (2009) 1.40
Identifying new cannabis use with urine creatinine-normalized THCCOOH concentrations and time intervals between specimen collections. J Anal Toxicol (2009) 1.16
Quantification and comparison of marijuana smoking practices: blunts, joints, and pipes. Drug Alcohol Depend (2010) 1.15
Estimating community drug abuse by wastewater analysis. Environ Health Perspect (2008) 1.12
Cannabis and sport. Br J Sports Med (2006) 1.00
Differentiating new cannabis use from residual urinary cannabinoid excretion in chronic, daily cannabis users. Addiction (2010) 0.98
Crash culpability relative to age and sex for injured drivers using alcohol, marijuana or cocaine. Annu Proc Assoc Adv Automot Med (2005) 0.98
Cannabis in sport: anti-doping perspective. Sports Med (2011) 0.86
Nonsmoker Exposure to Secondhand Cannabis Smoke. III. Oral Fluid and Blood Drug Concentrations and Corresponding Subjective Effects. J Anal Toxicol (2015) 0.82
Postmortem diagnosis and toxicological validation of illicit substance use. Addict Biol (2008) 0.79
Why should Cannabis be Considered Doping in Sports? Front Psychiatry (2013) 0.78
Bupropion reduces some of the symptoms of marihuana withdrawal in chronic marihuana users: a pilot study. Subst Abuse (2012) 0.77
A preliminary evaluation of the relationship of cannabinoid blood concentrations with the analgesic response to vaporized cannabis. J Pain Res (2016) 0.75
Rapid elimination of Carboxy-THC in a cohort of chronic cannabis users. Int J Legal Med (2015) 0.75
Sustained cocaine abstinence in methadone maintenance patients through voucher-based reinforcement therapy. Arch Gen Psychiatry (1996) 2.95
Clinical pharmacology of buprenorphine: ceiling effects at high doses. Clin Pharmacol Ther (1994) 2.90
Blood cannabinoids. I. Absorption of THC and formation of 11-OH-THC and THCCOOH during and after smoking marijuana. J Anal Toxicol (1993) 2.31
Ultrasonographic measurement of liver length in the small-for-gestational-age fetus. Am J Obstet Gynecol (1999) 2.11
Differentiating new marijuana use from residual drug excretion in occasional marijuana users. J Anal Toxicol (1998) 1.99
Assessment of cocaine use with quantitative urinalysis and estimation of new uses. Addiction (1997) 1.79
Cocaine inhibition of ligand binding at dopamine, norepinephrine and serotonin transporters: a structure-activity study. Life Sci (1990) 1.68
Blood cannabinoids. II. Models for the prediction of time of marijuana exposure from plasma concentrations of delta 9-tetrahydrocannabinol (THC) and 11-nor-9-carboxy-delta 9-tetrahydrocannabinol (THCCOOH) J Anal Toxicol (1993) 1.66
Changes in mood, craving, and sleep during short-term abstinence reported by male cocaine addicts. A controlled, residential study. Arch Gen Psychiatry (1990) 1.54
Physicians' ethical beliefs about cost-control arrangements. Arch Intern Med (2000) 1.54
The metabolism and excretion of buprenorphine in humans. Drug Metab Dispos (1985) 1.49
Buprenorphine treatment of pregnant opioid--dependent women: maternal and neonatal outcomes. Drug Alcohol Depend (2001) 1.46
Cocaine use early in treatment predicts outcome in a behavioral treatment program. J Consult Clin Psychol (1998) 1.46
Transabdominal versus transvaginal ultrasound in the diagnosis of polycystic ovaries in a population of randomly selected women. Ultrasound Obstet Gynecol (1994) 1.45
Effects of military experience on mental health problems and work behavior. Med Care (1992) 1.42
Detection of marijuana use by oral fluid and urine analysis following single-dose administration of smoked and oral marijuana. J Anal Toxicol (2001) 1.41
Morphological changes in human head hair subjected to various drug testing decontamination strategies. Forensic Sci Int (2007) 1.41
An ethics curriculum for teaching emergency medicine residents. Ann Emerg Med (1990) 1.38
Perceived financial incentives, HMO market penetration, and physicians' practice styles and satisfaction. Health Serv Res (1999) 1.38
Effects of delivery rate and non-contingent infusion of cocaine on cocaine self-administration in rhesus monkeys. Psychopharmacology (Berl) (1998) 1.32
Detection times of marijuana metabolites in urine by immunoassay and GC-MS. J Anal Toxicol (1995) 1.29
The prevalence of polycystic ovaries on ultrasound scanning in a population of randomly selected women. Aust N Z J Obstet Gynaecol (1994) 1.29
Substantial work disability and earnings losses in individuals less than age 65 with osteoarthritis: comparisons with rheumatoid arthritis. J Clin Epidemiol (1989) 1.26
Vibration perception threshold: influence of age, height, sex, and smoking, and calculation of accurate centile values. Diabet Med (1991) 1.20
MRSA in the community. N Z Med J (1996) 1.20
Subjective and physiologic effects of intravenous buprenorphine in humans. Clin Pharmacol Ther (1993) 1.19
Arterial and venous cocaine plasma concentrations in humans: relationship to route of administration, cardiovascular effects and subjective effects. J Pharmacol Exp Ther (1996) 1.16
Strategies to promote the use of advance directives in a residency outpatient practice. J Gen Intern Med (1996) 1.15
Differential access in the receipt of antiretroviral drugs for the treatment of AIDS and its implications for survival. Arch Intern Med (2000) 1.14
The brief abstinence test: voucher-based reinforcement of cocaine abstinence. Drug Alcohol Depend (2000) 1.12
Protective Value for Infants of Various Types of Vitamin D Fortified Milk: A Preliminary Report. Am J Public Health Nations Health (1932) 1.08
Characterization of the absorption phase of marijuana smoking. Clin Pharmacol Ther (1992) 1.07
Elimination of cocaine and metabolites in plasma, saliva, and urine following repeated oral administration to human volunteers. J Anal Toxicol (2000) 1.07
Disposition of heroin and its metabolites in heroin-related deaths. J Anal Toxicol (1994) 1.07
Forensic drug testing for opiates: I. Detection of 6-acetylmorphine in urine as an indicator of recent heroin exposure; drug and assay considerations and detection times. J Anal Toxicol (1991) 1.06
Monitoring cocaine use in substance-abuse-treatment patients by sweat and urine testing. J Anal Toxicol (1999) 1.05
Mental health and the labor force participation of older workers. Inquiry (1989) 1.04
An in vitro method for studying the retrograde intra-axonal transport of horseradish peroxidase in sympathetic neurons. Brain Res (1978) 1.03
HTLV-III seropositivity in 1971-1972 parenteral drug abusers--a case of false positives for evidence of viral exposure? N Engl J Med (1986) 1.02
Acute and residual effects of marijuana: profiles of plasma THC levels, physiological, subjective, and performance measures. Pharmacol Biochem Behav (1990) 1.01
Relationship of plasma buprenorphine and norbuprenorphine to withdrawal symptoms during dose induction, maintenance and withdrawal from sublingual buprenorphine. Addiction (1998) 1.01
Comparison of heroin and cocaine concentrations in saliva with concentrations in blood and plasma. J Anal Toxicol (1995) 1.01
Manpower needs in academic emergency medicine. Ann Emerg Med (1990) 1.00
Effects of HMO market penetration on physicians' work effort and satisfaction. Health Aff (Millwood) (1998) 1.00
Sigma compounds derived from phencyclidine: identification of PRE-084, a new, selective sigma ligand. J Pharmacol Exp Ther (1991) 1.00
Urinary excretion half-life of 11-nor-9-carboxy-delta9-tetrahydrocannabinol in humans. Ther Drug Monit (1998) 0.99
The effects of chronic buprenorphine treatment on cocaine and food self-administration by rhesus monkeys. J Pharmacol Exp Ther (1992) 0.98
Butyrylcholinesterase accelerates cocaine metabolism: in vitro and in vivo effects in nonhuman primates and humans. Drug Metab Dispos (2000) 0.97
Sweat testing for cocaine, codeine and metabolites by gas chromatography-mass spectrometry. J Chromatogr B Biomed Sci Appl (1999) 0.95
Monitoring opiate use in substance abuse treatment patients with sweat and urine drug testing. J Anal Toxicol (2000) 0.95
Brainstem pain modulating circuitry is sexually dimorphic with respect to mu and kappa opioid receptor function. Pain (2000) 0.95
Comparison of self-reported drug use with quantitative and qualitative urinalysis for assessment of drug use in treatment studies. NIDA Res Monogr (1997) 0.95
Expenditures on services for persons with acquired immunodeficiency syndrome under a Medicaid home and community-based waiver program. Are selection effects important? Med Care (1997) 0.94
Induction of testicular sarcomas in Fischer rats by intratesticular injection of nickel subsulfide. Cancer Res (1978) 0.94
Passive inhalation of marijuana smoke: urinalysis and room air levels of delta-9-tetrahydrocannabinol. J Anal Toxicol (1987) 0.93
Comparative metabolism of hydrocodone in man, rat, guinea pig, rabbit, and dog. Drug Metab Dispos (1978) 0.93
Suspiciousness induced by four-hour intravenous infusions of cocaine. Preliminary findings. Arch Gen Psychiatry (1988) 0.92
HMO penetration and physicians' earnings. Med Care (1999) 0.92
Measurement of heroin and its metabolites by isotope-dilution electron-impact mass spectrometry. Clin Chem (1993) 0.90
Urinary excretion profiles for total morphine, free morphine, and 6-acetylmorphine following smoked and intravenous heroin. J Anal Toxicol (2001) 0.90
63Ni electron-capture gas chromatographic assay for buprenorphine and metabolites in human urine and feces. J Chromatogr (1985) 0.89
Attenuation of cocaine-induced locomotor activity by butyrylcholinesterase. Exp Clin Psychopharmacol (1998) 0.88
Medicare fees and small area variations in breast-conserving surgery among elderly women. Med Care Res Rev (2001) 0.88
Cocaine and metabolite excretion in saliva under stimulated and nonstimulated conditions. J Anal Toxicol (1993) 0.87
Detection and quantitation of urinary 11-nor-delta-9-tetrahydrocannabinol-9-carboxylic acid, a metabolite of tetrahydrocannabinol, by capillary gas chromatography and electron impact mass fragmentography. J Anal Toxicol (1987) 0.87
Forensic drug testing for opiates, III. Urinary excretion rates of morphine and codeine following codeine administration. J Anal Toxicol (1991) 0.87
Strong foundations for undergraduate education. Ann Emerg Med (1990) 0.87
Metabolism and Disposition of Prescription Opioids: A Review. Forensic Sci Rev (2015) 0.87
Inhibitory effect of topical application of a green tea polyphenol fraction on tumor initiation and promotion in mouse skin. Carcinogenesis (1992) 0.87
Fetal liver length in normal and isoimmunized pregnancies. Am J Obstet Gynecol (1989) 0.87
Breast cancer treatment choice and mastectomy length of stay: a comparison of HMO and other privately insured women. Inquiry (1998) 0.87
Use of buprenorphine in the treatment of opiate addiction. I. Physiologic and behavioral effects during a rapid dose induction. Clin Pharmacol Ther (1989) 0.86
Forensic drug testing for opiates. VI. Urine testing for hydromorphone, hydrocodone, oxymorphone, and oxycodone with commercial opiate immunoassays and gas chromatography-mass spectrometry. J Anal Toxicol (1995) 0.86
Diazepam and methadone blood levels following concurrent administration of diazepam and methadone. Drug Alcohol Depend (1986) 0.86
Physiologic effects and plasma kinetics of beta-phenylethylamine and its N-methyl homolog in the dog. J Pharmacol Exp Ther (1982) 0.86
Florida's Medicaid AIDS waiver: an assessment of dimensions of quality. Health Care Financ Rev (1995) 0.86
Acute effects of smoking marijuana on hormones, subjective effects and performance in male human subjects. Pharmacol Biochem Behav (1986) 0.85
Augmented femoral venous return. Ann Thorac Surg (1993) 0.85
Cocaine and metabolite concentrations in plasma during repeated oral administration: development of a human laboratory model of chronic cocaine use. J Anal Toxicol (1998) 0.85
Induction of renal cancers in rats by intrarenal injection of nickel subsulfide. J Environ Pathol Toxicol (1980) 0.85
The urinary excretion profile of naltrexone and metabolites in man. Drug Metab Dispos (1975) 0.85
Premier 'smokeless cigarettes' can be used to deliver crack. JAMA (1989) 0.84
The association of hepatitis delta virus and hepatitis B virus in parenteral drug abusers. 1971 to 1972 and 1986 to 1987. Arch Intern Med (1990) 0.84
Use of quantitative urinalysis in monitoring cocaine use. NIDA Res Monogr (1997) 0.83
Cocaine contamination of United States paper currency. J Anal Toxicol (1997) 0.83
Forensic drug testing for opiates. II. Metabolism and excretion rate of morphine in humans after morphine administration. J Anal Toxicol (1991) 0.83
Cocaine disposition in meconium from newborns of cocaine-abusing mothers and urine of adult drug users. J Anal Toxicol (1996) 0.82
Contact highs and urinary cannabinoid excretion after passive exposure to marijuana smoke. Clin Pharmacol Ther (1986) 0.82
Oxymorphone metabolism and urinary excretion in human, rat, guinea pig, rabbit, and dog. Drug Metab Dispos (1983) 0.82
Cardiopulmonary arrest secondary to lightning injury in a pregnant woman. Ann Emerg Med (1986) 0.81
In vitro characterization of cocaine binding sites in human hair. J Pharmacol Exp Ther (1997) 0.81
Drug testing with alternative matrices I. Pharmacological effects and disposition of cocaine and codeine in plasma, sebum, and stratum corneum. J Anal Toxicol (1998) 0.81
Testing human hair for drugs of abuse. IV. Environmental cocaine contamination and washing effects. Forensic Sci Int (1995) 0.81
Ownership of clinical laboratories by referring physicians: effects on utilization, charges, and profitability. Med Care (1994) 0.81
Determination of delta 9-tetrahydrocannabinol in human blood and saliva by high-performance liquid chromatography with amperometric detection. J Chromatogr (1987) 0.81
Cocaine and metabolite elimination patterns in chronic cocaine users during cessation: plasma and saliva analysis. J Anal Toxicol (2000) 0.81
Identification of hydrocodone in human urine following controlled codeine administration. J Anal Toxicol (2000) 0.80
Ultrasonographic surveillance in red blood cell alloimmunization. Am J Obstet Gynecol (2001) 0.80
Simultaneous assay of cocaine, heroin and metabolites in hair, plasma, saliva and urine by gas chromatography-mass spectrometry. J Chromatogr B Biomed Appl (1994) 0.79